文献速递前列腺癌

3T多参数MRI有无直肠内线圈对前列腺癌检测及PI-RADS v2分级的比较:全mount病理对照

Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADS™ version 2 Category and Staging with Whole Mount Histopathology Correlation.
PubMed 文献 · J Urol · 2019-01-01

该回顾性病例对照研究纳入429例前列腺切除术前行3T多参数MRI的患者,比较使用与不使用直肠内线圈对前列腺癌检测及分期的性能,以全mount病理为参考。结果显示两组总体和指数肿瘤检测率相似,但直肠内线圈组对后部及外周带肿瘤检测率更高,对前部及移行带肿瘤检测率更低。

要点

  • 3T多参数MRI有无直肠内线圈对总体和指数前列腺癌检测率相似。
  • 直肠内线圈组后部及外周带前列腺癌检测率显著更高。
  • 直肠内线圈组前部及移行带前列腺癌检测率显著更低。

核心结论

  • 3T多参数MRI使用与不使用直肠内线圈对总体和指数前列腺癌检测率相似,但直肠内线圈组对后部及外周带肿瘤检测更高,对前部及移行带肿瘤检测更低。

研究设计与样本

  • 回顾性HIPAA合规、机构审查委员会批准的病例对照研究,纳入2009年7月至2016年12月在前列腺切除术前接受3T多参数MRI的患者。
  • 共分析429例患者(平均年龄61.8±7岁)的871个全mount病理病灶,其中直肠内线圈组260例529个病灶,无直肠内线圈组169例342个病灶。

主要发现

  • 总体肿瘤检测率为49.6%(432/871),直肠内线圈组为50.5%(267/529),无直肠内线圈组为48.2%(165/342)。
  • 指数肿瘤检测率总体为77.6%(333/429),直肠内线圈组为78.5%(204/260),无直肠内线圈组为76.3%(129/169)。
  • 直肠内线圈组与无直肠内线圈组前部病灶检测率分别为35.9%(66/184)和48.4%(76/157),p=0.019。
  • 直肠内线圈组与无直肠内线圈组后部病灶检测率分别为58%(200/345)和48.1%(89/185),p=0.025。
  • 直肠内线圈组与无直肠内线圈组移行带病灶检测率分别为37.3%(41/110)和54.4%(62/114),p=0.010;外周带病灶检测率分别为53.7%(225/419)和45.2%(103/228),p=0.033。

关键数值与推荐

  • 调整临床和病理因素后,直肠内线圈组仅显示对外周带和后部前列腺癌检测更高。

临床怎么用

  • 3T多参数MRI不使用直肠内线圈即可获得与使用线圈相似的总体和指数前列腺癌检测率。
  • 对于怀疑前部或移行带前列腺癌的患者,需注意不使用直肠内线圈可能检测率更低;对于后部或外周带肿瘤,使用直肠内线圈可能提高检测率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the performance of 3 Tesla multiparametric magnetic resonance imaging with and without an endorectal coil to detect prostate cancer with a whole mount histopathology reference. MATERIALS AND METHODS: This retrospective HIPAA (Health Insurance Portability and Accountability Act) compliant, institutional review board approved, case-control study included patients who underwent 3 Tesla multiparametric magnetic resonance imaging with and without an endorectal coil from July 2009 to December 2016 prior to prostatectomy. The tumor detection rate was calculated for total and index lesions. Lesion magnetic resonance imaging and histopathology features were compared between the 2 groups. Using SPSS®, version 24 p <0.05 was considered significant. RESULTS: A total of 871 whole mount histopathology lesions in 429 patients with a mean ± SD age of 61.8 ± 7 years were included in analysis. The subcohorts with and without an endorectal coil comprised 260 and 169 patients with a total of 529 and 342 lesions, respectively. The overall tumor detection rates in all patients, and in the endorectal coil and nonendorectal coil subcohorts were 49.6% (432 of 871 patients), 50.5% (267 of 529) and 48.2% (165 of 342), respectively. The index tumor detection rates overall, and in the endorectal coil and nonendorectal coil subcohorts were 77.6% (333 of 429 patients), 78.5% (204 of 260) and 76.3% (129 of 169), respectively. In the endorectal coil and nonendorectal coil subcohorts we detected 35.9% (66 of 184) and 48.4% (76 of 157) of anterior lesions (p = 0.019), 58% (200 of 345) and 48.1% (89 of 185) of posterior lesions (p = 0.025), 37.3% (41 of 110) and 54.4% (62 of 114) of transition zone lesions (p = 0.010), and 53.7% (225 of 419) and 45.2% (103 of 228) of peripheral lesions (p = 0.033), respectively. After adjusting for clinical and pathological factors the endorectal coil group only showed higher detection of peripheral and posterior prostate cancer. CONCLUSIONS: We found that 3 Tesla multiparametric magnetic resonance imaging with and without an endorectal coil had similar detection of overall and index prostate cancer. However, the endorectal coil subcohort had significantly higher detection of posterior and peripheral prostate cancer, and lower detection of anterior and transition zone prostate cancer.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Mirak SA, Shakeri S, Bajgiran AM, et al. Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADS™ version 2 Category and Staging with Whole Mount Histopathology Correlation. J Urol. 2019. PMID: 30273608. doi:10.1016/j.juro.2018.09.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。